Original immunophenotype of blood endothelial progenitor cells and microparticles in patients with isolated arterial erectile dysfunction and late onset hypogonadism: Effects of androgen replacement therapy

Aging Male

Volumn 14, Issue 3, 2011, Pages 183-189

  La Vignera, Sandro ^a   Condorelli, Rosita ^a   Vicari, Enzo ^a   D'Agata, Rosario ^a   Calogero, Aldo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

androgen replacement therapy; Endothelial dysfunction; erectile dysfunction; late onset hypogonadism

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; TESTOSTERONE; VASCULAR ENDOTHELIAL CADHERIN;

ADULT; ANDROGEN THERAPY; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOMETRY; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; ERECTILE DYSFUNCTION; HUMAN; HYPOGONADISM; IMMUNOPHENOTYPING; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT CONTRAINDICATION;

AGE OF ONSET; ANDROGENS; ANTIGENS, CD; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; CELL-DERIVED MICROPARTICLES; DRUG MONITORING; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HEMANGIOBLASTS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; IMMUNOPHENOTYPING; IMPOTENCE, VASCULOGENIC; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; RISK FACTORS; TESTOSTERONE; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 80051535540     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685538.2010.550661     Document Type: Article

References (46)

1. Francomano D, Bruzziches R, Natali M, Aversa A, Spera G. Cardiovascular effect of testosterone replacement therapy in aging male. Acta Biomed 2010;81 (Suppl 1): 101-106.
2. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003;42:1149-1160. (Pubitemid 37188333)
3. Sugiyama S, Kugiyama K, Aikawa M, Nakamura S, Ogawa H, Libby P. Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: Involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol 2004;24:1309-1314. (Pubitemid 38880026)
4. Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, McKinlay JB. Erectile dysfunction and coronary risk factors: Prospective results from the Massachusetts male aging study. Prev Med 2000;30:328-338. (Pubitemid 30211093)
5. Russel ST, Khandheria BK, Nehra A. Erectile dysfunction and cardiovascular disease. Mayo Clin Proc 2004;79:782-794. (Pubitemid 38691830)
6. Baumhakel M, Werner N, Bohm M, Nickening G. Circulating endothelial progenitor cells correlate with erectile function in patients with coronary heart disease. Eur Heart J 2006;27:2184-2188. (Pubitemid 44412832)
7. Gazzaruso C, Solerte SB, Pujia A, Coppola A, Vezzoli M, Salvucci F, Valenti C, Giustina A, Garzaniti A. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease. A potential protective role for statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol 2008;51:2040-2044. (Pubitemid 351689055)
8. Diemer T. Testosterone and erectile dysfunction. Urologe A 2010;49:26-31.
9. Mikhail N. Does testosterone have a role in erectile function? Am J Med 2006;119:373-382.
10. Foresta C, Caretta N, Lana A, De Toni L, Biagioli A, Ferlin A, Garolla A. Reduced number of circulating endothelial progenitor cells in hypogonadal men. J Clin Endocrinol Metab 2006;91:4599-4602. (Pubitemid 44833444)
11. Foresta C, De Toni L, Biagioli A, Ganz F, Magagna S, Caretta N. Increased levels of osteocalcin-positive endothelial progenitor cells in patients affected by erectile dysfunction and cavernous atherosclerosis. J Sex Med 2009;7:751-757.
12. Real C, Caiado F, Dias S. Endothelial progenitors in vascular repair and angiogenesis: How many are needed and what to do? Cardiovasc Hematol Disord Drug Targets 2008;8:185-193.
13. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-697.
14. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, Nickenig G. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003;93:e17-e24.
15. Kong D, Melo LG, Gnecchi M, Zhang L, Mostoslavsky G, Liew CC, Pratt RE, Dzau VJ. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004;110:2039-2046. (Pubitemid 39331919)
16. Urbich C, Dimmeler S. Endothelial progenitor cells: Characterization and role in vascular biology. Circ Res 2004; 95:343-353. (Pubitemid 39100452)
17. Güven H, Shepherd RM, Bach RG, Capoccia BJ, Link DC. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 2006;48:1579-1587. (Pubitemid 44528190)
18. Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, Bhavsar JR, Yoder MC, Haneline LS, Ingram DA. Human CD34+AC133+VEGFR-2+cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007;35:1109-1118. (Pubitemid 46921310)
19. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008;28:1584-1595.
20. Timmermans F, Van Hauwermeiren F, De Smedt M, Raedt R, Plasschaert F, De Buyzere ML, Gillebert TC, Plum J, Vandekerckhove B. Endothelial outgrowth cells are not derived from CD133+cells or CD45+hematopoietic precursors. Arterioscler Thromb Vasc Biol 2007;27:1572-1579. (Pubitemid 46986112)
21. Papayannopoulou T. Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood 2004;103:1580-1585. (Pubitemid 38268945)
22. Schatteman GC, Dunnwald M, Jiao C. Biology of bone marrowderived endothelial cell precursors. Am J Physiol Heart Circ Physiol 2007;292:1-18.
23. Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, Delia D, Sutherland DR, Baker MA, Greaves MF. Expression of the CD34 gene in vascular endothelial cells. Blood 1990;75:2417-2426. (Pubitemid 20202322)
24. Ryu JK, Zhang LW, Jin HR, Piao S, Choi MJ, Tuvshintur B, Tumurbaatar M, Shin SH, Han JY, Kim WJ, Suh JK. Derangements in endothelial cell-to-cell junctions involved in the pathogenesis of hypercholesterolemia-induced erectile dysfunction. J Sex Med 2009;6:1893-1907.
25. Shet AS. Characterizing blood microparticles: Technical aspects and challenges. Vasc Health Risk Manag 2008;4:769-774.
26. Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol 2009;5:673-681.
27. Aversa A, Bruzziches R, Francomano D, Rosano G, Isidori AM, Lenzi A, Spera G. Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: Results from a 24-month, randomized, double-blind, placebocontrolled study. J Sex Med 2010;7:3495-3503. doi: 10.1111/ j.1743-6109.2010.01931.x.
28. Katabami T, Kato H, Asahina T, Hinohara S, Shin T, Kawata T, Ohta A, Iwamoto T, Tanaka Y. Serum free testosterone and metabolic syndrome in Japanese men. Endocr J 2010;57:533-539.
29. Lunenfeld B. The relationship between sex hormones and the metabolic syndrome. Acta Biomed 2010;81 (Suppl 1): 79-84.
30. Kintzel PE, Chase SL, Schultz LM, O'Rourke TJ. Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer. Pharmacotherapy 2008;28:1511-1522.
31. Esposito K, Ciotola M, Giugliano F, Schisano B, Improta L, Improta MR, Beneduce F, Rispoli M, De Sio M, Giugliano D. Endothelial microparticles correlate with erectile dysfunction in diabetic men. Int J Impot Res 2007;19:161-166. (Pubitemid 46340832)
32. Esposito K, Ciotola M, Giugliano F, Sardelli L, Giugliano F, Maiorino MI, Beneduce F, De Sio M, Giugliano D. Phenotypic assessment of endothelial microparticles in diabetic and nondiabetic men with erectile dysfunction. J Sex Med 2008;5:1436-1442. (Pubitemid 351803109)
33. Wang C, Nieschlag E, Swerdloff RS, Behre H, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, et al. ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2009;12:5-10.
34. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5 item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319-326. (Pubitemid 30052683)
35. Benson CB, Aruny JE, Vickers MA Jr. Correlation of duplex sonography with arteriography in patients with erectile dysfunction. Am J Roentgenol 1993;160:71-73. (Pubitemid 23022808)
36. Speel TG, van Langen H, Wijkstra H, Meuleman EJ. Penile duplex pharmaco-ultrasonography revisited: Revalidation of the parameters of the cavernous arterial response. J Urol 2003;169:216-220. (Pubitemid 35461591)
37. Jones TH, Saad F. The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. Atherosclerosis 2009;207:318-327.
38. Traish AM, Saad F, Feeley RJ, Guay A. The dark side of testosterone deficiency. III. Cardiovascular disease. J Androl 2009;30:477-494.
39. Esposito K, Ciotola M, Maiorino MI, Giugliano F, Autorino R, De Sio M, Jannini E, Lenzi A, Giugliano D. Circulating CD34+KDR+endothelial progenitor cells correlate with erectile function and endothelial function in overweight men. J Sex Med 2009;6:107-114.
40. Foresta C, Caretta N, Lana A, Cabrelle A, Palù G, Ferlin A. Circulating endothelial progenitor cells in subjects with erectile dysfunction. Int J Impot Res 2005;17:288-290. (Pubitemid 40675515)
41. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005;106:1525-1531. (Pubitemid 41208561)
42. Adams V, Lenk K, Linke A, Lenz D, Erbs S, Sandri M, Tarnok A, Gielen S, Emmrich F, Schuler G, Hambrecht R. Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia. Arterioscler Thromb Vasc Biol 2004;24:684-490.
43. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, De Ferrari GM, Ferlini M, Goffredo L, Bertoletti A, et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005;105:199-206. (Pubitemid 40053083)
44. Sandri M, Adams V, Gielen S, Linke A, Lenk K, Kränkel N, Lenz D, Erbs S, Scheinert D, Mohr FW, et al. Effects of exercise and ischemia on mobilization and functional activation of bloodderived progenitor cells in patients with ischemic syndromes: Results of 3 randomized studies. Circulation 2005;111:3391-3399. (Pubitemid 40923392)
45. Cho HJ, Kim HS, Lee MM, Kim DH, Yang HJ, Hur J, Hwang KK, Oh S, Choi YJ, Chae IH, et al. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelization and reduce vascular inflammation after intravascular radiation. Circulation 2003;108:2918-2925. (Pubitemid 37517821)
46. George J, Goldstein E, Abashidze S, Deutsch V, Shmilovich H, Finkelstein A, Herz I, Miller H, Keren G. Circulating endothelial progenitor cells in patients with unstable angina: Association with systemic inflammation. Eur Heart J 2004;25:1003-1008. (Pubitemid 38869417)